Literature DB >> 20852923

Pentraxin 3 values during normal pregnancy.

Anders Larsson1, Maria Palm, Johanna Helmersson, Ove Axelsson.   

Abstract

Pentraxin 3 (PTX3) is an inflammatory molecule that has been reported to be a promising early biomarker for subsequent preeclampsia. The levels of PTX3 vary during pregnancy and it is thus a need to establish reference intervals during normal pregnancy. Repeated blood samples were collected from 52 healthy pregnant females. The samples were divided according to collection time into the following groups: week 7-17, week 17-24, week 24-28, week 28-31, week 31-34, week 34-38, before delivery and after delivery. The samples were analyzed for PTX3 with a sandwich ELISA and the 2.5 and 97.5 percentiles for each sample period was calculated. There was a continuous increase of serum PTX3 as pregnancy progressed. The increase was most evident after week 31 with the highest levels just before delivery.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20852923     DOI: 10.1007/s10753-010-9252-x

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  15 in total

1.  Plasma and tissue expression of the long pentraxin 3 during normal pregnancy and preeclampsia.

Authors:  Patrizia Rovere-Querini; Simona Antonacci; Giacomo Dell'Antonio; Anna Angeli; Giada Almirante; Elena Dal Cin; Luca Valsecchi; Chiara Lanzani; Maria Grazia Sabbadini; Claudio Doglioni; Angelo A Manfredi; Maria Teresa Castiglioni
Journal:  Obstet Gynecol       Date:  2006-07       Impact factor: 7.661

2.  Elevated maternal levels of the long pentraxin 3 (PTX3) in preeclampsia and intrauterine growth restriction.

Authors:  Irene Cetin; Veronica Cozzi; Fabio Pasqualini; Manuela Nebuloni; Cecilia Garlanda; Luca Vago; Giorgio Pardi; Alberto Mantovani
Journal:  Am J Obstet Gynecol       Date:  2006-04-21       Impact factor: 8.661

3.  Human renal epithelial cells produce the long pentraxin PTX3.

Authors:  Alma J Nauta; Simone de Haij; Barbara Bottazzi; Alberto Mantovani; Maria C Borrias; Jan Aten; Maria Pia Rastaldi; Mohamed R Daha; Cees van Kooten; Anja Roos
Journal:  Kidney Int       Date:  2005-02       Impact factor: 10.612

4.  Cell-specific regulation of PTX3 by glucocorticoid hormones in hematopoietic and nonhematopoietic cells.

Authors:  Andrea Doni; Giovanna Mantovani; Chiara Porta; Jan Tuckermann; Holger M Reichardt; Anna Kleiman; Marina Sironi; Luca Rubino; Fabio Pasqualini; Manuela Nebuloni; Stefano Signorini; Giuseppe Peri; Antonio Sica; Paolo Beck-Peccoz; Barbara Bottazzi; Alberto Mantovani
Journal:  J Biol Chem       Date:  2008-08-14       Impact factor: 5.157

5.  Chorionic gonadotropin up-regulates long pentraxin 3 expression in myeloid cells.

Authors:  Hui Wan; Cornelia G van Helden-Meeuwsen; Cecilia Garlanda; Lonneke M E Leijten; Virginia Maina; Nisar A Khan; Hemmo A Drexhage; Alberto Mantovani; Robbert Benner; Marjan A Versnel
Journal:  J Leukoc Biol       Date:  2008-08-06       Impact factor: 4.962

6.  Elevation of plasma levels of the long pentraxin 3 precedes preeclampsia in pregnant patients with type 1 diabetes.

Authors:  Maria Teresa Castiglioni; Marina Scavini; Rubina Cavallin; Federica Pasi; Susanna Rosa; Maria Grazia Sabbadini; Patrizia Rovere-Querini
Journal:  Autoimmunity       Date:  2009-05       Impact factor: 2.815

7.  Maternal pentraxin 3 deficiency compromises implantation in mice.

Authors:  Susanne Tranguch; Anindita Chakrabarty; Yong Guo; Haibin Wang; Sudhansu K Dey
Journal:  Biol Reprod       Date:  2007-05-30       Impact factor: 4.285

8.  Regulation of PTX3, a key component of humoral innate immunity in human dendritic cells: stimulation by IL-10 and inhibition by IFN-gamma.

Authors:  Andrea Doni; Mosca Michela; Barbara Bottazzi; Giuseppe Peri; Sonia Valentino; Nadia Polentarutti; Cecilia Garlanda; Alberto Mantovani
Journal:  J Leukoc Biol       Date:  2006-02-03       Impact factor: 4.962

9.  Pentraxin 3 in amniotic fluid: a novel association with intra-amniotic infection and inflammation.

Authors:  Laura Cruciani; Roberto Romero; Edi Vaisbuch; Juan Pedro Kusanovic; Tinnakorn Chaiworapongsa; Shali Mazaki-Tovi; Pooja Mittal; Giovanna Ogge; Francesca Gotsch; Offer Erez; Sun Kwon Kim; Zhong Dong; Percy Pacora; Ronald F Lamont; Lami Yeo; Sonia S Hassan; Gian Carlo Di Renzo
Journal:  J Perinat Med       Date:  2010-03       Impact factor: 1.901

Review 10.  Pattern recognition by pentraxins.

Authors:  Alok Agrawal; Prem Prakash Singh; Barbara Bottazzi; Cecilia Garlanda; Alberto Mantovani
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

View more
  6 in total

Review 1.  Impact of Systemic Inflammation on the Progression of Gestational Diabetes Mellitus.

Authors:  Tove Lekva; Errol R Norwitz; Pål Aukrust; Thor Ueland
Journal:  Curr Diab Rep       Date:  2016-04       Impact factor: 4.810

2.  Plasma C-Reactive Protein and Pentraxin-3 Reference Intervals During Normal Pregnancy.

Authors:  Lina Wirestam; Sofia Pihl; Muna Saleh; Jonas Wetterö; Christopher Sjöwall
Journal:  Front Immunol       Date:  2021-08-02       Impact factor: 7.561

3.  Maternal serum pentraxin 3 level in early pregnancy for prediction of gestational diabetes mellitus.

Authors:  Xiaoxian Qu; Jingyi Zhuang; Chuanlu Xu; Zisheng Ai; Ling Yuan; Yuping Tang; Qun Shu; Yirong Bao; Huan Han; Hao Ying
Journal:  Ann Transl Med       Date:  2019-12

4.  Host-protective effect of circulating pentraxin 3 (PTX3) and complex formation with neutrophil extracellular traps.

Authors:  Kenji Daigo; Takao Hamakubo
Journal:  Front Immunol       Date:  2012-12-13       Impact factor: 7.561

5.  Low circulating pentraxin 3 levels in pregnancy is associated with gestational diabetes and increased apoB/apoA ratio: a 5-year follow-up study.

Authors:  Tove Lekva; Annika Elisabeth Michelsen; Jens Bollerslev; Errol R Norwitz; Pål Aukrust; Tore Henriksen; Thor Ueland
Journal:  Cardiovasc Diabetol       Date:  2016-02-03       Impact factor: 9.951

6.  Plasma pentraxin 3 is higher in early ovarian hyperstimulation syndrome than in uncomplicated in vitro fertilization cycle of high-risk women.

Authors:  Kati Korhonen; Leila Unkila-Kallio; Henrik Alfthan; Esa Hämäläinen; Aila Tiitinen; Tomi Mikkola; Juha Tapanainen; Hanna Savolainen-Peltonen
Journal:  Arch Gynecol Obstet       Date:  2020-05-05       Impact factor: 2.344

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.